molnupiravir

1 articles

Merck Discusses Using COVID Antiviral Drug for Ebola Response

Merck executives are exploring molnupiravir as an Ebola treatment amid a worsening outbreak in the DRC. The company also noted potential applications for its existing Ebola vaccine technology against

reuters · 2026-06-01 09:55

Product Info

Name (EN)	EIDD-2801
CAS No.	2349386-89-4
Molecular Formula	C13H19N3O7
Type	product
Other Names (EN)	EIDD 2801;EIDD-2801;EIDD2801;molnupiravir;2349386-89-4;MK-4482;UNII-YA84KI1VEW;YA84KI1VEW;Molnupiravir [USAN];((2R,3S,4R,5R)-3,4-Dihydroxy-5-(4-(hydroxyimino)-2-oxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-2-yl)methyl isobutyrate